Acucela INC

Acucela was founded in 2010. Acucela specializes in Deaf Or Blind Home. Acucela has 4 employees and estimated revenues of $150,000.00.

Acucela Inc. researches, develops and intends to commercialize therapies for unmet or underserved needs in ophthalmology. The Company currently has three product candidates in clinical development: ACU-4429 for dry age-related macular degeneration, rebamipide for dry eye syndrome and OPA-6566 for ocular hypertension and glaucoma, all of which are being co-developed in the United States with...